FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 65162-360 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA215067
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (800 mg/1)
Marketing started20250219
Package count1

External sources

Source: openFDA. Public-domain (CC0).